Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Over 10,000 participants in clinical trials used tirzepatide for up to two years without any demonstrated increase in thyroid nodule formation or thyroid cancer incidence
Generally, Semaglutide is prescribed for adults with a Body Mass Index (BMI) of 30 or greater (obesity), or a BMI of 27 or greater (overweight) who also have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Laboratory research record on GLP-1S [PMID: 40146102] PubMed laboratory record discussing GLP-1S in a research context
Our prior authorization article covers this in more detail: Medicare Prior Authorization Changes in Washington 2026
Medications like Wegovy and Zepbound are tailored for weight management and are designed to reach higher doses to suppress appetite and aid in weight loss
US$ 21.34
US$ 26.83
US$ 20.74
